DR. ARASH A. HORIZON M.D. NPI 1881694131

NPI Details

DR. Arash A. Horizon, M.D. is a rheumatology internal medicine in Los Angeles, CA with 28 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. DR. Arash A. Horizon, M.D. NPI is 1881694131. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF CALIFORNIA, SAN DIEGO SCHOOL OF MEDICINE
Graduation Year:1998

The provider's business location address is:

8640 W 3RD ST
SUITE 300
LOS ANGELES, CA
ZIP 90048-384
Phone: (310) 659-7878
Fax: (310) 659-7117

The NPI 1881694131 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, vedolizumab, 1 mg (HCPCS:J3380)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, omalizumab, 5 mg (HCPCS:J2357)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, immune globulin (bivigam), 500 mg (HCPCS:J1556)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Ustekinumab, for intravenous injection, 1 mg (HCPCS:J3358)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
• Measurement of complement function (immune system proteins) (HCPCS:86161)
• Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
• Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Injection of drug or substance into vein (HCPCS:96374)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Vitamin d-3 level (HCPCS:82306)
• Tuberculosis test, enumeration of t-cells (HCPCS:86481)
• X-ray of hand, minimum of 3 views (HCPCS:73130)
• X-ray of wrist, minimum of 3 views (HCPCS:73110)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• X-ray of foot, minimum of 3 views (HCPCS:73630)
• Measurement of dna antibody, native or double stranded (HCPCS:86225)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Ferritin (blood protein) level (HCPCS:82728)
• Measurement of substance using immunoassay technique (HCPCS:83520)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Uric acid level, blood (HCPCS:84550)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• X-ray of lower and sacral spine, minimum of 4 views (HCPCS:72110)
• X-ray of knee, 3 views (HCPCS:73562)
• Glutamyltransferase (liver enzyme) level (HCPCS:82977)
• Influenza vaccine, quadrivalent, 0.5 ml dosage (HCPCS:90688)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
• Rheumatoid factor level (HCPCS:86431)
• Screening test for autoimmune disorder (HCPCS:86038)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Antibody identification test for white blood cell antibodies (HCPCS:86021)
• X-ray of joint between lower spine and hip bone, 1-2 views (HCPCS:72200)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Hemoglobin a1c level, by device for home use (HCPCS:83037)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Aspiration and/or injection of fluid from small joint (HCPCS:20600)
• Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS:G2212)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Hyaluronan or derivative, gel-one, for intra-articular injection, per dose (HCPCS:J7326)
• Folic acid level, serum (HCPCS:82746)
• X-ray of upper spine, 6 or more views (HCPCS:72052)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• X-ray of hip, 1 view (HCPCS:73501)
• Beta 2 glycoprotein 1 antibody (autoantibody) measurement (HCPCS:86146)
• Cardiolipin antibody (tissue antibody) measurement (HCPCS:86147)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• X-ray of knee, 4 or more views (HCPCS:73564)
• Sex hormone binding globulin (protein) level (HCPCS:84270)
• Testosterone (hormone) level, total (HCPCS:84403)
• X-ray of knee, 1-2 views (HCPCS:73560)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Aspiration and/or injection of fluid from medium joint (HCPCS:20605)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• X-ray of joint between lower spine and hip bone, 3 or more views (HCPCS:72202)
• Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment (HCPCS:77085)

The enumeration date for this NPI number is 7/28/2005 and was last updated on 10/23/2013.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.